DEC-NET Serial number GB597 |
|
Published online | 06/09/2006 15.00.00 |
Last updated | 06/09/2006 14.59.09 |
| |
Other protocol ID number | N/A |
This trial has been approved by an ethics committee |
Current trial status | Open (actively recruiting new participants) |
First subject enrolment Target N. of subjects |
10/2004 320 |
Major Disease (ICD9 class) | UNSPECIFIED OTITIS MEDIA |
Experimental drug |
Probiotic
Treatment regimen (dosage and duration) Information not given |
Gender | Both |
Age (range) | 6 months to 11 years |
Eligibility criteria |
Inclusion criteria |
Children with a previous history of otalgia between 6 months and 11 years |
Exclusion criteria |
Consent not given |
Trial design/methodology |
Phase | 4 |
Kind of study | Efficacy
|
Design | Controlled Randomised Blinded Double blind
|
Purpose of study |
To determine the effectiveness of a course of probiotics in reducing reported episodes of acute otalgia and ear problems over the winter months, and consultations with otitis media |
Primary outcomes |
Effectiveness of a course of probiotics in reducing reported episodes of acute otalgia and ear problems |
Secondary outcomes |
None |
Summary of study design, objectives, and ongoing research findings |
A double blind randomised placebo trial to investigate the use of probiotics in the prevention of episodes of otitis in general practice |